Cabot Corp CBT
We take great care to ensure that the data presented and summarized in this overview for CABOT CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CBT
View all-
Black Rock Inc. New York, NY7.22MShares$797 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.26MShares$690 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.86MShares$536 Million0.08% of portfolio
-
Earnest Partners LLC Atlanta, GA3.36MShares$371 Million1.5% of portfolio
-
State Street Corp Boston, MA2.1MShares$232 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC1.63MShares$179 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.35MShares$149 Million0.03% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.3MShares$143 Million0.52% of portfolio
-
Geode Capital Management, LLC Boston, MA1.26MShares$139 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA1.23MShares$136 Million2.63% of portfolio
Latest Institutional Activity in CBT
Top Purchases
Top Sells
About CBT
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Insider Transactions at CBT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 03
2024
|
Sean D Keohane President and CEO |
SELL
Open market or private sale
|
Direct |
25,617
-3.65%
|
$2,587,317
$101.76 P/Share
|
Sep 03
2024
|
Sean D Keohane President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,617
+6.7%
|
$999,063
$39.54 P/Share
|
Aug 27
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct |
16,390
-11.81%
|
$1,704,560
$104.31 P/Share
|
Aug 27
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,390
+10.42%
|
$819,500
$50.12 P/Share
|
Aug 27
2024
|
Jeff Ji Zhu Executive Vice President |
SELL
Open market or private sale
|
Direct |
13,711
-7.16%
|
$1,425,944
$104.13 P/Share
|
Aug 26
2024
|
Jeff Ji Zhu Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,201
-1.24%
|
$127,306
$106.19 P/Share
|
Aug 20
2024
|
Hobart Kalkstein Executive Vice President |
SELL
Open market or private sale
|
Direct |
5,457
-4.17%
|
$545,700
$100.05 P/Share
|
Aug 20
2024
|
Hobart Kalkstein Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,457
+3.95%
|
$218,280
$40.97 P/Share
|
Aug 19
2024
|
Hobart Kalkstein Executive Vice President |
SELL
Open market or private sale
|
Direct |
14,863
-19.42%
|
$1,486,300
$100.91 P/Share
|
Aug 19
2024
|
Hobart Kalkstein Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,863
+16.26%
|
$594,520
$40.97 P/Share
|
Aug 08
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct |
11,082
-8.34%
|
$1,086,036
$98.06 P/Share
|
Aug 08
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,082
+7.6%
|
$554,100
$50.12 P/Share
|
Aug 07
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct |
23,274
-2.89%
|
$2,350,674
$101.08 P/Share
|
Aug 07
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,274
+14.0%
|
$1,163,700
$50.12 P/Share
|
Jul 12
2024
|
Thierry Fj Vanlancker |
BUY
Grant, award, or other acquisition
|
Direct |
816
+50.0%
|
$76,704
$94.99 P/Share
|
May 16
2024
|
Hobart Kalkstein Executive Vice President |
SELL
Open market or private sale
|
Direct |
12,000
-16.28%
|
$1,212,000
$101.55 P/Share
|
May 16
2024
|
Hobart Kalkstein Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+14.0%
|
$480,000
$40.97 P/Share
|
May 15
2024
|
Hobart Kalkstein Executive Vice President |
SELL
Open market or private sale
|
Direct |
187
-0.3%
|
$19,261
$103.0 P/Share
|
May 15
2024
|
Hobart Kalkstein Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
187
+0.3%
|
$7,480
$40.97 P/Share
|
May 10
2024
|
Karen A Kalita SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
13,764
-28.63%
|
$1,390,164
$101.73 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 133K shares |
---|---|
Exercise of conversion of derivative security | 305K shares |
Payment of exercise price or tax liability | 91.6K shares |
---|---|
Bona fide gift | 855 shares |
Open market or private sale | 328K shares |